Lipid metabolic pathways, including FASN and stearoyl-CoA desaturase (SCD) signaling, also play pivotal roles in maintaining cancer stem cell (CSC) populations, thereby driving metastasis and drug resistance in HCC (47). This evidence concerns the gene FASN and hepatocellular carcinoma.